FARE Thanks Congress, President for Protecting Food Allergy Research
New Federal Spending Bill Also Helps Food Allergic School Children
MCLEAN, Va., (March 25, 2024) – Food Allergy Research and Education (FARE, foodallergy.org), the leading non-profit organization engaged in food allergy advocacy and the largest private funder of food allergy research in the US, applauds the passage of the federal government’s fiscal year 2024 (FY’24) spending bill which included provisions to protect food allergy research funding and continued support for schools helping children with life-threatening food allergies. Passed by Congress and signed into law by President Biden over the weekend, the new law underscores FARE’s advocacy efforts to protect federal investment in food allergy research.
Specifically, the bill provides $12.1 million for the National Institute of Allergy and Infectious Disease (NIAID) Consortium of Food Allergy Research (CoFAR) enabling CoFar’s clinical research network to continue funding its research into new treatments and therapies. Xolair, the second FDA-approved drug for the food allergy community, was developed within CoFAR.
FARE also noted that lawmakers continued $2 million in funding to the Centers for Disease Control & Prevention (CDC) through its Chronic Disease Prevention and Health Promotion work to help protect the nearly six million children with life-threatening food allergies in our schools. FARE and other food allergy stakeholders are currently working to update the CDC’s Voluntary Guidance to schools which was first developed back in 2013.
Sung Poblete, PhD, RN, CEO of FARE said, "Research for the disease of food allergy lags far behind other serious, chronic diseases. Therefore, we express our profound gratitude on behalf of the food allergy community to members of Congress, particularly those who are part of the Food Allergy Research Caucus, for their support and dedication in advocating for these critical priorities throughout the year, ensuring the continuation of vital funding."
FARE is grateful both to Congress and President Biden for their support of the food allergy community and their recognition of food allergy research as critical to the lives of millions of Americans.
Media Contact:
About FARE
FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.